-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Integrated Biopharma Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2012 to 2024.
- Integrated Biopharma Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 30.6M shares, a 2.28% increase year-over-year.
- Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 30.9M shares, a 3.09% increase from 2023.
- Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 29.9M shares, a 7.34% decline from 2022.
- Integrated Biopharma Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 32.3M shares, a 0.65% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)